Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
In Re Lannett Company, Inc. Derivative Litigation
Case Number:
1:19-cv-00888
Court:
Nature of Suit:
Multi Party Litigation:
Derivative Litigation
Judge:
Firms
Companies
Sectors & Industries:
-
October 23, 2020
Lannett Drug Price-Fixing Settlement Gets Del. Judge's OK
Lannett Company Inc. and its stockholders secured a Delaware federal court's approval late Thursday for a settlement to end a suit accusing the company of lying to investors about the pharmaceutical company's part in multi-district government price-fixing probes and litigation.
-
May 13, 2019
Lannett Hit With Del. Suit Over Generic-Drug Price-Fixing
A Lannett Company Inc. shareholder filed a derivative suit Monday in Delaware federal court against former and current company officers in connection with an alleged industrywide generic-drug price-fixing scheme that has led to multiple other suits.